Results 91 to 100 of about 121,849 (300)

Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging

open access: yes, 2004
peer reviewedSTUDY OBJECTIVES: To study the ability of positron emission tomography (PET) using 18-fluorodeoxyglucose (FDG) to distinguish between benign and malignant disease in exudative pleural effusions and pleural thickening.
Cataldo, Didier   +6 more
core   +1 more source

External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Diuretic resistance in worsening heart failure (HF) is associated with poorer outcomes and, although common, can be challenging to identify. The recently developed BAN‐ADHF score can potentially identify patients with worsening HF at risk of diuretic resistance.
Dominic M. Alfonso   +10 more
wiley   +1 more source

Pleural Disease

open access: yes, 2020
This Monograph provides the clinician with an up-to-date summary of the substantial evidence in our understanding of pleural disease. It covers key aspects relevant to clinicians, including mechanisms, pathophysiology, epidemiology, diagnostics, relevant experimental models and interventions.
José Cárdenas-García   +1 more
openaire   +2 more sources

Sensitivity of Polymerase Chain Reaction Reaction for Pleural Tuberculosis according to the Amount of Pleural Effusion Specimens

open access: yes, 2007
Background: For the diagnosis of pleural tuberculosis, polymerase chain reaction (PCR) of pleural effusion specimens has shown very low sensitivity, which might be due to the small number of bacilli in the samples. The purpose of this investigation is to
문진욱
core   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

open access: yesBMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan   +8 more
wiley   +1 more source

Chiari I Malformation: Review and Update of Current Treatment Options

open access: yesClinical Anatomy, EarlyView.
ABSTRACT The pathophysiology of Chiari malformation type I (CM‐I) is complex, involving structural abnormalities at the craniovertebral junction that result in herniation of the cerebellar tonsils through the foramen magnum. In this study, we aim to present and evaluate current treatment options for CM‐I, with a focus on evidence‐based clinical ...
Jordan J. Lo   +11 more
wiley   +1 more source

A Prospective Study of Ziehl-Neelsen Stain and Mycobacterial Culture of Pleural Fluid and Closed Pleural Biopsy Specimen in Tuberculous Pleural Effusion [PDF]

open access: yes, 2000
Background : Tuberculous pleural effusion is the most common extrapulmonary site of all disease due to Mycobacterium tuberculosis. The diagnosis of tuberculous pleural effusion is most often established by histologic examination of pleural biopsy ...
김영삼
core  

Safety and outcome of medical thoracoscopy as diagnostic tool for pleural and pulmonary diseases

open access: yes, 2016
BackgroundThe accurate diagnosis of pleural effusion is challenging because even after thoracocentesis and/or closed pleural biopsy, 25–40% of pleural effusion remains undiagnosed.
Mousa Mohamed Elshamly   +1 more
core   +1 more source

Pleural fluid findings as prognostic factors for malignant pleural mesothelioma [PDF]

open access: yes, 2008
The aim of this study was to determine the prognostic value of pleural fluid glucose, lactate dehydrogenase (LDH), albumin, total protein, and total leukocyte levels in patients with malignant pleural mesothelioma.
Gonlugur, Ugur   +1 more
core   +1 more source

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy